ArticleInternational journal of molecular sciences2023

MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer.

Weiru Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.